## Review setup
- **Input scope** Abstract only
- **Assessment boundary** Claims and evidence presented in the abstract; no access to methods, figures, tables, or supplementary material
- **Shared manuscript claim summary** The authors propose a machine learning model combining protein sequence evolutionary information with kernel sparse representation via L(2,1)-matrix norm for predicting DNA-binding proteins. They report cross-validation accuracy of 81.37% on PDB1075 and independent test accuracy of 83.9% on PDB186, claiming these outperform other methods and demonstrate effectiveness and feasibility.
- **Visible evidence base** Abstract text only; no methodological details, dataset descriptions, baseline comparisons, or statistical analyses are provided
- **Missing materials affecting confidence** Full methods, algorithm formulation, feature encoding details, dataset composition and preprocessing, baseline method descriptions, error bars or significance tests, and any figures or tables

## Reviewer
- **Overall assessment** The abstract presents a plausible application of kernel sparse representation to a well-studied bioinformatics prediction problem. However, the limited information provided prevents verification of the core claims. The reported accuracies are modest and the claim of outperformance lacks comparative context. The methodological novelty relative to existing sparse representation and DNA-binding protein predictors is unclear from the abstract alone.
- **Who would be interested in the results, and why** Researchers in computational biology and bioinformatics, particularly those working on protein function prediction, DNA-binding protein identification, and applications of sparse representation and kernel methods to biological sequence classification. The work may also interest method developers in machine learning seeking new application domains.
- **Major strengths** The problem is of practical importance in functional genomics and drug design. The combination of evolutionary information with kernel sparse representation is a reasonable technical direction. The use of two benchmark datasets (PDB1075 and PDB186) for cross-validation and independent testing is a standard and appropriate evaluation strategy.
- **Major Concerns**  
  - R1-M1  
  - R1-M2  
  - R1-M3
- **Minor Comments**  
  - R1-m1  
  - R1-m2  
  - R1-m3
- **Technical failings that need to be addressed before the case is established** R1-M1 (lack of comparative evidence), R1-M2 (unverifiable methodological novelty), R1-M3 (absence of statistical rigor)
- **Assessment against Nature-style criteria**  
  - Originality: Not assessable from the abstract. The combination of kernel sparse representation with evolutionary features may be novel, but no comparison to prior sparse representation-based predictors is provided.  
  - Scientific importance: Moderate. DNA-binding protein prediction is a useful but mature problem; incremental accuracy gains are of limited broad significance.  
  - Interdisciplinary readership: Limited. The work is primarily of interest to computational biologists and machine learning practitioners; the abstract does not frame broader biological insights.  
  - Technical soundness: Not assessable. No methodological details or statistical validation are provided.  
  - Readability for nonspecialists: The abstract is understandable but uses technical terms without sufficient context for a general scientific audience.
- **Recommendation posture** Currently not established from the provided evidence. The abstract alone does not support the claims of effectiveness, feasibility, or outperformance. A full manuscript with methods, data, and comparative analyses would be required for a substantive evaluation.

### Major Concerns

- **Concern ID** R1-M1  
- **Severity** Major  
- **Blocking** Yes  
- **Axis** Evidence sufficiency  
- **Claim pointer** The authors claim that their method "outperformed the other methods to some extent" on both PDB1075 and PDB186.  
- **Evidence pointer** Abstract, location not provided  
- **Concern** The abstract provides no information about which other methods were compared, how many baselines were used, what their performance values were, or whether the reported improvements are statistically significant. The phrase "to some extent" is vague and does not constitute a quantitative comparative claim.  
- **Why it matters** A central claim of the paper is that the proposed method improves upon existing approaches. Without explicit baseline results and significance testing, the claim of outperformance is unverifiable and potentially misleading.  
- **Resolution test** Provide a table or text listing all baseline methods, their reported accuracies on the same datasets, and the results of appropriate statistical tests (e.g., McNemar's test or paired bootstrap) demonstrating that the observed differences are significant.

- **Concern ID** R1-M2  
- **Severity** Major  
- **Blocking** Yes  
- **Axis** Methodological clarity  
- **Claim pointer** The authors state that they "combine protein sequence evolutionary information with a classification method based on kernel sparse representation" and use "L(2,1)-matrix norm."  
- **Evidence pointer** Abstract, location not provided  
- **Concern** The abstract does not explain how the kernel sparse representation is formulated, how the L(2,1)-matrix norm is applied, what kernel function is used, or how evolutionary information (e.g., PSSM profiles) is integrated. Without these details, the method cannot be reproduced or evaluated for novelty.  
- **Why it matters** Reproducibility is a fundamental requirement for scientific claims. The lack of methodological detail prevents readers from understanding what is actually proposed and whether it differs meaningfully from prior sparse representation-based predictors.  
- **Resolution test** In the full manuscript, provide a complete algorithmic description, including the optimization problem, the kernel construction, the role of the L(2,1)-norm, and the feature encoding pipeline. Clarify the novelty relative to existing sparse representation methods in bioinformatics.

- **Concern ID** R1-M3  
- **Severity** Major  
- **Blocking** Yes  
- **Axis** Statistical rigor  
- **Claim pointer** The authors report single accuracy values of 81.37% (PDB1075 cross-validation) and 83.9% (PDB186 independent test) as evidence of effectiveness.  
- **Evidence pointer** Abstract, location not provided  
- **Concern** No measures of variance, confidence intervals, or multiple-run results are reported. Single-point accuracy estimates are insufficient to establish that the method performs reliably, especially given the modest margins typically seen in this problem domain.  
- **Why it matters** Without variance estimates, readers cannot assess the stability of the reported performance or whether the results are within the range of random variation. This undermines the claim of effectiveness.  
- **Resolution test** Report mean and standard deviation (or confidence intervals) across multiple cross-validation folds or independent runs, and provide per-class metrics (sensitivity, specificity, MCC) to give a fuller picture of performance.

### Minor Comments

- **Concern ID** R1-m1  
- **Severity** Minor  
- **Axis** Clarity of terminology  
- **Affected element** Title and abstract  
- **Evidence pointer** Abstract, location not provided  
- **Issue** The phrase "Kernel Sparse Representation via L(2,1)-matrix norm" is technically dense and may confuse readers unfamiliar with matrix norm notation. The abstract does not define L(2,1)-norm or explain its relevance.  
- **Required correction** Add a brief definition or intuitive explanation of the L(2,1)-matrix norm and its role in the method, either in the abstract or in the introduction of the full manuscript.

- **Concern ID** R1-m2  
- **Severity** Minor  
- **Axis** Dataset description  
- **Affected element** Abstract  
- **Evidence pointer** Abstract, location not provided  
- **Issue** The datasets PDB1075 and PDB186 are mentioned without any description of their composition, such as sequence length distribution, positive-to-negative ratio, or redundancy level.  
- **Required correction** In the full manuscript, describe the datasets in detail, including how they were constructed, whether redundancy was removed, and the class balance.

- **Concern ID** R1-m3  
- **Severity** Minor  
- **Axis** Generalizability  
- **Affected element** Abstract  
- **Evidence pointer** Abstract, location not provided  
- **Issue** The abstract claims the method is "effective and feasible" but does not discuss potential limitations, such as dependence on evolutionary information quality or scalability to larger datasets.  
- **Required correction** Add a brief discussion of limitations and potential failure modes in the full manuscript, and consider testing on additional benchmark datasets to strengthen generalizability claims.

## Risk / unsupported claims
- The claim that the proposed method "outperformed the other methods to some extent" is unsupported because no baseline methods or comparative results are provided.
- The claim that the method is "effective and feasible" is unsupported because no statistical validation, variance measures, or independent replication are reported.
- The methodological novelty of combining kernel sparse representation with L(2,1)-matrix norm and evolutionary information is unassessable from the abstract alone.
- The generalizability of the method beyond the two reported datasets is unassessable.